Clinical trials: A significant part of cancer care uniondemocrat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uniondemocrat.com Daily Mail and Mail on Sunday newspapers.
SimBioSys, a TechBio company that is redefining precision medicine for cancer by utilizing artificial intelligence (AI) and biophysical modeling to unlock the power of spatial biophysics, announced today that it has partnered with Mayo Clinic on a strategic collaboration agreement to develop innovative digital precision medicine treatments for patients with breast cancer.
SimBioSys and Mayo Clinic Enter Strategic Collaboration to Advance AI-powered Digital Precision Medicine Platform for Cancer Patients streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
For women with multiple ipsilateral breast cancer, breast-conserving therapy (BCT) with adjuvant radiation results in a low five-year local recurrence rate.
WEDNESDAY, April 12, 2023 (HealthDay News) For women with multiple ipsilateral breast cancer, breast-conserving therapy (BCT) with adjuvant radiation results in a low five-year local recurrence rate, according to a study published online March 28 in the Journal of Clinical Oncology. Judy C. Boughey, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues